Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

被引:27
|
作者
Edwards, Morven S. [1 ]
Lane, Heidi J. [1 ]
Hillier, Sharon L. [2 ,3 ,4 ,5 ]
Rench, Marcia A. [1 ]
Baker, Carol J. [1 ,6 ]
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Univ Pittsburgh, Sch Med, Dept Obstet, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Gynecol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Sch Med, Dept Reprod Sci, Pittsburgh, PA USA
[5] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA
[6] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Group B Streptococcus; Vaccine; Antibody; Glycoconjugate; Polysaccharide; Durability; TOXOID CONJUGATE VACCINE; PREGNANT-WOMEN; DISEASE; ADULTS; IMMUNOGENICITY; INFECTION; SAFETY; LEVEL; IA;
D O I
10.1016/j.vaccine.2012.04.048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The duration of functional activity of group B streptococcal (CBS) glycoconjugate vaccine-induced capsular polysaccharide-specific (CPS) IgG was evaluated among healthy adult responders. Opsonophagocytic activity declined significantly from a 4-week post-immunization peak, but substantial functional activity, exceeding 1 log(10) reduction in CBS cfu/mL, was retained at 18 months to 2 years post-immunization for each CBS type assessed. The persistence of functional antibody activity when CBS CPS-specific IgG concentrations decline, although remaining significantly higher than pre-immunization levels, suggests that long-term protection may be expected from candidate CBS glycoconjugates administered to this population. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4123 / 4126
页数:4
相关论文
共 50 条